Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

29.09
Delayed Data
As of Jun 28
 +1.14 / +4.08%
Today’s Change
26.97
Today|||52-Week Range
34.88
-14.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues28.0B25.6B26.0B24.7B
 
 
 
 
 
Cost of Goods Sold3.9B3.7B4.2B3.4B
 
 
 
 
 
Depreciation And Amortization2.3B2.7B3.1B2.7B
 
 
 
 
 
 
Operating ExpensesGross Income21.8B19.2B18.6B18.6B
 
 
 
 
 
General Expenses13.1B13.1B16.1B15.0B
 
 
 
 
 
Other Operating Expenses0.0021.9M0.000.00
 
 
Research And Development4.2B4.2B4.9B5.6B
 
 
 
 
 
Total Operating Expenses19.3B19.5B23.5B21.1B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income8.7B6.1B2.5B3.6B
 
 
 
 
 
Extraordinary Credit178.3M403.8M15.9M387.3M
 
 
 
 
 
Extraordinary Charge-1.8B-3.6B-1.8B-2.1B
 
 
 
 
 
Interest Expense On Debt426.8M411.8M416.3M391.3M
 
 
 
 
 
Equity In Earnings0.000.00-6.0M-16.0M
 
 
 
Other Expenses1.0B710.9M887.4M1.5B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income7.7B3.3B1.2B3.1B
 
 
 
 
 
Income Taxes-1.4B-694.0M-11.0M-242.5M
 
 
 
 
 
Minority Interest-30.1M-15.0M-2.0M-998.1K
 
 
 
 
 
Net Income6.3B2.5B1.2B2.8B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$2.50$1.02$0.49$1.11
 
 
 
 
 
EPS Diluted$2.49$1.02$0.49$1.11